ReviewClinical epigenetics2024

Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.

Yuxi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.